VinayRajaMD

Oncology • North Kansas City, MO

Hematologic Oncology

Assistant Professor, Internal Medicine, University Kansas School of Medicine

Join to view full profile

Dr. Raja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Raja's full profile

Already have an account?

Office
2750 Clay Edwards Dr
ste 215
North Kansas City, MO 64116
Phone+1 913-574-1050

Fax+1 913-574-1056

Education & Training

University of Texas Medical Branch HospitalsFellowship, Medical Oncology, 2001 - 2003
University of HawaiiFellowship, Geriatric Medicine (Internal Medicine), 2000 - 2001
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 2000
Bangalore Medical CollegeClass of 1995

Certifications & Licensure

MO State Medical License 2002 - 2026
IN State Medical License 1998 - 2025
KS State Medical License 2000 - 2025
HI State Medical License 2000 - 2001
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Completed
Phase 3

Publications & Presentations

PubMed

Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.
Qamar J Khan, Colleen Bohnenkamp, Taylor E Monson, Milind A Phadnis, Lauren Clark
JCO Oncology Advances. 2025-01-01
51 citations
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer...
Priyanka Sharma, Bruce F. Kimler, Anne O'Dea, Lauren Nye, Yen Y. Wang
Clinical Cancer Research. 2021-02-15
Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 2. Mixed carcinoid-adenocarcinoma of the appendix.
Vinay Raja, Roja Balakrishnan, Wade Bollinger, Dwayne Crabtree, Edward Downey
Journal of Clinical Oncology. 2005-10-01